Scott D. Morenstein is Director at Celator Pharmaceuticals Inc (CPXX). They have made 3 open-market trades across 2 companies since 2015, most recently 2019-11-21.
CIK 0001576113
3 open-market purchases totalling $6.8M since 2015, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.